Materials / Specialty ChemicalsUpdated 2026-05-10 22:07 UTC

NSE/ADVENZYMES stock hub

NSE/ADVENZYMES has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ADVENZYMESis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

40B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ADVENZYMES

In the news

Latest news · NSE/ADVENZYMES

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23

P25 16.8P50 26.6P75 37.7

Trailing P/E23.7

P25 15.6P50 25.5P75 40.1

ROE11

P25 5.4P50 10.6P75 16.7

ROIC16.9

P25 3.4P50 7.8P75 13.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ADVENZYMES market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

INR

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	338
Employees Change	15%
Employees Change Percent	4.64
Enterprise value	INR 34.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Specialty Chemicals
Isin	INE837H01020
Last refreshed	2026-05-10
Market cap	INR 40B
Price	INR 362
Price currency	INR
Rev Per Employee	23,094,349.11x
Sector	Materials
Sic	2860
Symbol	nse/ADVENZYMES
Website	https://www.advancedenzymes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.22%
EV Earnings	20.61x
EV/EBIT	15.53x
EV/EBITDA	13.17x
EV/FCF	33.25x
EV/Sales	4.45x
FCF yield	2.61%
Forward P/E	23.05x
P/B ratio	2.38x
P/E ratio	23.72x
P/S ratio	5.12x
PE Ratio10 Y	27.66x
PE Ratio3 Y	27.54x
PE Ratio5 Y	28.24x
PEG ratio	1.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	28.67%
EBITDA Margin	33.81%
FCF margin	13.39%
Gross margin	75.28%
Gross Profit	INR 5.9B
Gross Profit Growth	24.6%
Gross Profit Growth Q	42.72%
Gross Profit Growth3 Y	13.8%
Gross Profit Growth5 Y	8.2%
Net Income	INR 1.7B
Net Income Growth	28.68%
Net Income Growth Q	62.24%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	16.89%
Net Income Growth5 Y	2.94%
Pretax Margin	29.79%
Profit Margin	21.61%
Profit Per Employee	INR 5M
Profitable Years	18
ROA	8.09
Roa5y	7.19
ROCE	12.92
ROE	11.02
Roe5y	10.15
ROIC	16.9
Roic5y	14.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	29.77%
Cagr3y	11.34%
Cagr5y	-3.01%
Div CAGR3	73.25%
Div CAGR5	34.08%
EPS Growth	28.61
EPS Growth Q	62.03
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	16.82
EPS Growth5 Y	2.92
FCF Growth	-3.81%
FCF Growth3 Y	0.74%
FCF Growth5 Y	-6.14%
OCF Growth	10.02%
OCF Growth10 Y	5.32%
OCF Growth3 Y	3.76%
OCF Growth5 Y	-0.77%
Revenue Growth	22.56x
Revenue Growth Q	25.97x
Revenue Growth Quarters	5x
Revenue Growth Years	11x
Revenue Growth3 Y	13.02x
Revenue Growth5 Y	9.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.45
Assets	INR 18.4B
Cash	INR 7B
Current Assets	INR 10.4B
Current Liabilities	INR 1.1B
Debt	INR 320.1M
Debt EBITDA	INR 0.12
Debt Equity	INR 0.02
Debt FCF	INR 0.31
Equity	INR 16.8B
Interest Coverage	85.16
Liabilities	INR 1.6B
Long Term Assets	INR 8B
Long Term Liabilities	INR 489.2M
Net Cash	INR 6.7B
Net Cash By Market Cap	INR 16.7
Net Cash Growth	20.77%
Net Debt EBITDA	INR -2.53
Net Debt Equity	INR -0.4
Net Debt FCF	INR -6.39
Tangible Book Value	INR 12.2B
Tangible Book Value Per Share	INR 109
WACC	8.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.78
Inventory Turnover	1.15
Net Working Capital	INR 2.6B
Quick ratio	7.92
Working Capital	INR 9.4B
Working Capital Turnover	INR 0.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	1.96%
Dividend Growth Years	5%
Dividend per share	INR 5.2
Dividend Years	9
Dividend Yield	1.46%
Last Dividend	INR 1.2
Payout Ratio	35.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	29.75%
200-day SMA	309.9
3Y total return	38.04%
50-day SMA	300.1
50-day SMA vs 200-day SMA	50under200
5Y total return	-14.16%
All Time High	571
All Time High Change	-36.65%
All Time High Date	2024-09-16
All Time Low	98.1
All Time Low Change	268.76%
All Time Low Date	2020-03-23
ATR	12.74
Beta	0.69
Beta1y	0.17
Beta2y	0.43
Ch YTD	19.69
High	372
High52	372
High52 Date	2026-05-08
High52ch	-2.76%
Low	353.4
Low52	252
Low52 Date	2026-03-30
Low52ch	43.58%
Ma50ch	20.54%
Price vs 200-day SMA	16.73%
RSI	75.27
RSI Monthly	54.48
RSI Weekly	63.58
Sharpe ratio	0.75x
Sortino ratio	1.37
Total Return	1.42%
Tr YTD	19.69
Tr1m	28.55%
Tr1w	2.29%
Tr3m	25.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 2.2B
Operating Income Growth	41.63
Operating Income Growth Q	68.97
Operating Income Growth3 Y	21.21
Operating Income Growth5 Y	1.91
Operating margin	28.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36,918,423%
Net Borrowing	-91,200,000
Shares Insiders	39.67%
Shares Institutions	13.63%
Shares Out	111,926,800
Shares Qo Q	-0.23%
Shares Yo Y	0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 996.9M
Average Volume	336,152.95x
Bv Per Share	145.9
CAPEX	INR -522.3M
Ch1m	28.55
Ch1w	2.29
Ch1y	27.51
Ch3m	25.85
Ch3y	31.52
Ch5y	-18.71
Ch6m	16.54
Change	0.53%
Change From Open	0.54
Close	359.9
Days Gap	-0.01
Depreciation Amortization	400,930,000
Dollar Volume	152,102,852
Earnings Date	2026-05-09
EBIT	INR 2.2B
EBITDA	INR 2.6B
EPS	INR 15.06
F Score	7
FCF	INR 1B
FCF EV Yield	3.01x
FCF Per Share	INR 9.34
Financing CF	-703,660,000
Fiscal Year End	March
Founded	1,957
Goodwill	3,694,600,000
Graham Number	222.31891
Graham Upside	-38.54
Income Tax	INR 589.3M
Investing CF	-741,300,000
Is Primary Listing	1
Last Earnings Date	2026-05-09
Last Report Date	2026-03-31
Last Split Date	2017-05-25
Last Split Type	Forward
Lynch Fair Value	INR 75.3
Lynch Upside	-79.18
Ma150	303.4
Ma150ch	19.23%
Ma20	322
Ma20ch	12.34%
Net CF	145,300,000
Next Earnings Date	2026-05-15
Open	359.8
P FCF Ratio	38.25
P OCF Ratio	25.51
Payment Date	2025-08-05
Position In Range	44.89
Ppne	3,270,010,000
Price Date	2026-05-08
Price EBITDA	INR 15.15
Ptbv Ratio	3.29
Relative Volume	1.28x
Revenue	7,805,890,000x
SBC By Revenue	0.62x
Share Based Comp	48,600,000
Tax By Revenue	7.55x
Tax Rate	25.34%
Tr6m	16.54%
Volume	420,464

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/ADVENZYMES dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.5%

$5.20 annual per share

Payout ratio

+35.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+34.1%

5 consecutive years of growth

Total shareholder yield

+1.4%

Dividend yield + buyback yield combined

Performance

NSE/ADVENZYMES stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/ADVENZYMES?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.6%

Share of float held by funds and institutions

Insider ownership

+39.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/ADVENZYMES momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

75.3

Above 70: short-term overbought

Price vs 200-day MA

+16.7%

50/200-day relationship not available

Beta (5Y)

0.69

Less volatile than the market

Sharpe ratio

0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ADVENZYMES

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ADVENZYMES stock rating?

nse/ADVENZYMES is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ADVENZYMES analysis?

The full report lives at /stocks/nse/ADVENZYMES/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ADVENZYMES?

The latest report frames nse/ADVENZYMES around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ADVENZYMES page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.